CD34 and neoplasm: A number of tumour-derived factors with the capacity of altering the maturation of CD34+or CD14+precursors, including VEGF, TGF-β, IL-10 and PGE2, have been excluded to be implicated in this pathway (Kiertscher et al, 2000).